alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 2,451–2,475 of 7,816 matching trials · page 99 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease
NCT06570928
Cannabis; Placebo
Runs in: Brazil · 1 site 		PHASE2
other		 COMPLETED 72 Federal University of Latin American Integration
OTHER		 2025-05-25
Open-label Extension for Phase 3 Clinical Trials of Simufilam
NCT05575076
Simufilam
Runs in: Australia; Canada; Puerto Rico; South Korea; United States · 134 sites 		PHASE3
other		 TERMINATED 1,081 Cassava Sciences, Inc.
INDUSTRY		 2025-05-23
Testing the Efficacy of the "Syd" App on Improving Quality of Life and Mental Health Among University Students in the Kingdom of Saudi Arabia
NCT06979778
See Yourself Differently (syd) mobile app
Runs in: Saudi Arabia · 1 site 		NA
other		 NOT_YET_RECRUITING 600 iamYiam Limited
INDUSTRY		 2025-05-23
Transcranial Electromagnetic Treatment Against Alzheimer's Disease
NCT03927040
MemorEM 1000
Runs in: United States · 1 site 		NA
other		 COMPLETED 7 NeuroEM Therapeutics, Inc.
INDUSTRY		 2025-05-22
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
NCT04800588
California Cognitive Assessment Battery
Runs in: United States · 1 site 		NA
other		 RECRUITING 2,000 Neurobehavioral Systems, Inc.
INDUSTRY		 2025-05-22
Neural Mechanisms of Cognitive Assessment and Rehabilitation for Cognitive Decline
NCT05014893
multi-modal targeted intervention (e.g., cognitive training, exerci...
Runs in: China · 1 site 		NA
other		 RECRUITING 100 National Research Center for Rehabilitation Technical Aids
OTHER		 2025-05-22
Statins in Reducing Events in the Elderly Mind (STAREE-Mind) Imaging Substudy
NCT05586750
Atorvastatin 40 Mg Oral Tablet; Placebo
Runs in: Australia · 2 sites 		PHASE4
other		 ACTIVE_NOT_RECRUITING 341 Monash University
OTHER		 2025-05-22
Patient-Centered Dementia Care Practice Coaching Intervention
NCT06249204
Coaching Group
Runs in: United States · 1 site 		NA
other		 COMPLETED 449 Alzheimer's Disease and Related Disorders Association, Inc
OTHER		 2025-05-22
VR-based Physical Activity and Reminiscence Therapy
NCT06934720
aPAVRCT 		PHASE1|PHASE2
other		 NOT_YET_RECRUITING 100 Hong Kong University of Science and Technology
OTHER		 2025-05-22
Mid-frontal Delta/Theta and Cognitive Control
NCT06984757
Deep-brain Stimulation; Transcranial Magnetic Stimulation; Transcra...
Runs in: United States · 1 site 		NA
other		 ENROLLING_BY_INVITATION 635 Nandakumar Narayanan
OTHER		 2025-05-22
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
NCT06417086
Acupuncture; Sham Acupuncture; Donepezil
Runs in: China · 1 site 		NA
symptomatic-cholinergic		 RECRUITING 176 ZhanYJ
OTHER		 2025-05-21
Motivational Interviewing-Based Training
NCT06972030
Motivational interviewing
Runs in: Turkey (Türkiye) · 1 site 		NA
other		 NOT_YET_RECRUITING 80 Muş Alparslan University
OTHER		 2025-05-21
Co-design and Pilot Study in VR-based Physical Activity and Cognitive Training
NCT06982170
A physical activity and reminiscence therapy
Runs in: Hong Kong · 1 site 		NA
other		 COMPLETED 50 Hong Kong University of Science and Technology
OTHER		 2025-05-21
Case-Finding for Neurocognitive Disorders in Pavia
NCT06983119
Case-finding for Neurocognitive Disorders
Runs in: Italy · 1 site 		NA
other		 RECRUITING 490 IRCCS National Neurological Institute "C. Mondino" Foundation
OTHER		 2025-05-21
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
NCT06980207
LY03017; LY03017-Placebo
Runs in: China · 1 site 		PHASE1
other		 NOT_YET_RECRUITING 40 Luye Pharma Group Ltd.
INDUSTRY		 2025-05-20
Oral Health Parameter-Based Diabetes Type 2 Indication Using Machine Learning
NCT06981286
A dataset comprising participants withT2D will be used to evaluate ...
Runs in: Sweden · 1 site 		NA
other		 NOT_YET_RECRUITING 2,000 Blekinge Institute of Technology
OTHER		 2025-05-20
Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity
NCT04715750
[18F]-PI2620
Runs in: Germany · 1 site 		PHASE1
other		 COMPLETED 10 Life Molecular Imaging GmbH
INDUSTRY		 2025-05-18
Can Value Champions Reduce Inappropriate Prescribing for People With Dementia?
NCT05359679
Value Champion Training Program; No Intervention
Runs in: United States · 1 site 		NA
other		 COMPLETED 3,300 Kaiser Permanente
OTHER		 2025-05-18
A Second Intermediate-Size Expanded Access Protocol (EAP) for Pridopidine in People With Amyotrophic Lateral Sclerosis (Pridopidine EAP 2)
NCT06069934
Pridopidine
Runs in: Puerto Rico; United States · 32 sites 		NA
other		 NO_LONGER_AVAILABLE — Prilenia
INDUSTRY		 2025-05-18
MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment
NCT06177028
Lenalidomide 10 mg 		PHASE2
other		 NOT_YET_RECRUITING 45 St. Joseph's Hospital and Medical Center, Phoenix
OTHER		 2025-05-18
Generation of a Cellular Model of CADASIL From Skin Fibroblasts
NCT02032225
Skin biopsy
Runs in: France · 1 site 		NA
other		 COMPLETED 8 Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV		 2025-05-16
Couple and Spouse Caregiver in Huntington's Disease
NCT04394767
Runs in: France · 1 site 		NA
other		 TERMINATED 48 University Hospital, Lille
OTHER		 2025-05-16
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
NCT04700826
Direct Oral Anticoagulants
Runs in: United Kingdom · 1 site 		PHASE4
other		 RECRUITING 3,000 University of Birmingham
OTHER		 2025-05-16
A Dose Range Finding Study With Open-Label Extension to Evaluate the Safety of Oral LMI070/Branaplam in Early Manifest Huntington's Disease
NCT05111249
Branaplam; Placebo
Runs in: Canada; France; Germany; Hungary; Spain · 12 sites 		PHASE2
other		 TERMINATED 26 Novartis Pharmaceuticals
INDUSTRY		 2025-05-16
Mobile App Psychological Interventions for Family Dementia Caregivers
NCT05253443
Mentalizing Imagery Therapy and caregiver skills mobile application...
Runs in: United States · 1 site 		NA
other		 COMPLETED 135 Massachusetts General Hospital
OTHER		 2025-05-16

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →